Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

Treatment for chronic painful bowel condition to get NHS funding approval

April 19, 2024
admin
Vedolizumab (also called Entyvio) should be recommended as an option to treat moderate to severely active ulcerative colitis, according to final guidance by the National Institute for Health and Care Excellence (NICE).

National diabetes prevention drive launched

October 6, 2022
admin
The NHS and Public Health in England will start a major national initiative to prevent illness by unveiling the first ever at-scale National NHS Diabetes Prevention Programme.

NICE draft guidance recommends apixaban for blood

October 6, 2022
admin
The National Institute for Health and Care Excellence (NICE) has published a new draft guidance that recommends apixaban (Eliquis) as an option for treating and preventing potentially fatal blood clots.

New breast cancer genetic risk ‘hot-spots’ revealed

October 6, 2022
admin
Scientists have discovered another 15 genetic 'hot-spots' that can increase a woman's risk of developing breast cancer, according to research.

Five million patients to benefit from new era of patient care

October 6, 2022
admin
The NHS has chosen the first 29 'vanguard' geographies that will take the national lead on transforming care for patients in towns, cities and counties across England.

New research will help diabetics exercise more safely

October 6, 2022
admin
Reducing insulin dosage can help diabetics avoid blood sugar dips at night after exercising in the evening, a new study from Northumbria University has found.

Healthy-looking prostate cells mask cancer-causing mutations

April 18, 2024
admin
Prostate cells that look normal under the microscope may be hiding genetic mutations that could develop into cancer, prompting new ways to improve treatment for the disease, according to new.

Rheumatoid arthritis not given enough priority by the NHS

October 6, 2022
admin
The treatment of rheumatoid arthritis, which costs the NHS £560m annually, is not given a high enough priority according to a new report. 

Cardiovascular disease kills 51% of women in Europe and breast cancer kills 3%

October 6, 2022
admin
Cardiovascular disease (CVD) kills 51% of women in Europe and breast cancer kills 3%, bucking the misperception that CVD is a man's disease.

Deprivation of liberty: a practical guide

April 18, 2024
admin
The Deprivation of Liberty Safeguards (DoLS) are part of the Mental Capacity Act 2005. They aim to make sure that people in care homes, hospitals and supported living are looked after in a way that does not inappropriately restrict their freedom.

Lung cancer survival rates still lag behind in the UK

October 6, 2022
admin
Lung cancer survival rates in England should 'match the best in Europe' in order to save lives, insists a group of senior clinicians from the UK Lung Cancer Coalition (UKLCC). The call comes in response to a request from NHS England's new independent cancer taskforce for expert input into its forthcoming five-year plan

Uncommon neurological presentations and stroke mimics

April 18, 2024
Abhaya Gupta
Symptoms of stroke can be highly variable and there are several clinical conditions that could mimic a stroke. This article discusses the importance of detailed clinical history and competent examination in diagnosis.

Leukaemia gene faults accumulate with age

April 24, 2024
Alison Bloomer
Genetic mutations in blood cells that could develop into leukaemia become "almost inevitable" as people get older, new research suggest

GPs facing ‘David versus Goliath’ battle to provide out of hours care

October 6, 2022
admin
GPs who want to run out of hours services in their local areas should be awarded contracts without facing a 'David versus Goliath' struggle with large private companies, according to the Royal College of General Practitioners.

Zykadia recommended for approval in advanced non small cell lung cancer

October 6, 2022
admin
The European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation for Zykadia (ceritinib).

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy